Evidence map›Paper›PMID 32760277›Full record

ArticleFrontiers in pharmacology2020

Lina Xie, Ning Liu, Ye Xiao, Yanhui Liu, Chunge Yan, Gailing Wang, Xiangdong Jing

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. The Mechanism of Icariin in Regulating BMSCs for Treating Osteoporosis: A Review.Endocrine, metabolic & immune disorders drug targets · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Fabrication ofFrontiers in bioengineering and biotechnology · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Anodic TiONanomaterials (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lina XieDepartment of Stomatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Ning LiuSchool of Life Sciences, Hunan Normal University, Changsha, China.
Ye XiaoSchool of Life Sciences, Hunan Normal University, Changsha, China.
Yanhui LiuDepartment of Stomatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Chunge YanDepartment of Stomatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Gailing WangDepartment of Stomatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiangdong JingDepartment of Stomatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
First Affiliated Hospital of Guangzhou University of Chinese Medicine · CNHunan Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, we aimed to compare the effects of icariin (ICA) and bone morphogenetic protein-2 (BMP-2) on osteoblast proliferation and osteogenesis in bone defects. We found that

Indexed as

bone morphogenetic protein-2bone repairdyeing methodicariinnano-hydroxyapatite/collagen/polylactic acid (nHAC/PLA)osteogenesistraditional Chinese medicine

Identifiers

PMID32760277
PMCPMC7373825
OpenAlexW3042356334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.